Set in early 2021, this case is about Kino Biotech, a Singapore-based company producing health and beauty products, most notably its flagship brand, Kinohimitsu. Its operations and distribution have expanded globally, especially to Malaysia, Indonesia, and China. In April 2018, Kino Biotech...
